SzymczakS, SzpurkaA, LuZH, et al.Re: “A case report of poor response to selpercatinib in the presence of a 632_633 RET deletion” by Wijewardene et al. Thyroid, 2023; 33(12):1493–1495; doi: 10.1089/thy.2023.0258
2.
WijewardeneA, BastardK, WangB, et al.A case report of poor response to selpercatinib in the presence of a 632_633 RET deletion. Thyroid, 2023; 33(1):119–125; doi: 10.1089/thy.2021.0680
3.
RosenEY, WonHH, ZhengY, et al.The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers. Nat Commun, 2022; 13(1):1450; doi: 10.1038/s41467-022-28848-x
